Abstract
Oxymatrine extracted from Sophora flavescens Ait as a natural polyphenolic phytochemical has been demonstrated to exhibit anti-tumor effects on various cancers, including Gallbladder carcinoma (GBC). However, its underlying mechanisms of function are largely unknown in GBC cells. The present study is conducted to investigate the anti-tumor effects and the underlying mechanisms of oxymatrine on GBC cells in vitro and in vivo. The results showed that oxymatrine inhibited cell viability, metastatic ability and induced cell apoptosis in dose-dependent manners. Furthermore, we found that the expression of p-AKT, MMP-2, MMP-9 and the ratio of Bcl-2/Bax were significantly down-regulated, while the expression of PTEN was up-regulated in GBC cells. In addition, pretreatment with a specific PI3K/AKT activator (IGF-1) significantly antagonized the oxymatrine-mediated inhibition of GBC–SD cells. Subsequently, our in vivo studies showed that administration of oxymatrine induced a significant dose-dependent decrease in tumor growth. In conclusion, these findings indicated that the inhibition of cells proliferation, migration, invasion and the induction of apoptosis in response to oxymatrine in GBC cells, may function through the suppression of PTEN/PI3K/AKT pathway, which was considered as the vital signaling pathway in regulating tumorigenesis. These results suggested that oxymatrine might be a novel effective candidate as chemotherapeutic agent against GBC.
Similar content being viewed by others
References
Abahssain H, Afchain P, Meals N, Ismaili N, Rahali R, Rabit HM, Errihani H (2010) Chemotherapy in gallbladder carcinoma. Presse Med 39:1238–1245
And DJN, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–477
Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I (2006) Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys J 90:1546–1559
Boutros C, Gary M, Baldwin K, Somasundar P (2012) Gallbladder cancer: past, present and an uncertain future. Surg Oncol 21:183–191
Butler MS (2008) ChemInform abstract: natural products to drugs: natural product derived compounds in clinical trials. Cheminform 39:162–195
Cao YG, Jing S, Li L, Gao JQ, Shen ZY, Liu Y, Xing Y, Wu ML, Wang Y, Xu CQ, Sun HL (2010) Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens. Phytother Res 24:1844–1849
Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP, Wu BY (2012) Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells. World J Gastroenterol 18:4199–4206
Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260–1270
Chen H, Zhang J, Luo J, Lai F, Wang Z, Tong H, Lu D, Bu H, Zhang R, Lin S (2013a) Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-kappaB-mediated VEGF signaling pathway. Oncol Rep 30:589–595
Chen JS, Huang X, Wang Q, Huang JQ, Zhang L, Chen XL, Lei J, Cheng ZX (2013b) Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis 34:10–19
Dai ZJ, Gao J, Wu WY, Wang XJ, Li ZF, Kang HF, Liu XX, Ma XB (2007) Effect of matrine injections on invasion and metastasis of gastric carcinoma SGC-7901 cells in vitro. Zhong Yao Cai 30:815–819
Gan YH, Zhang S (2009) PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. Oral Oncol 45:e150–e154
Garcia-Echeverria C, Sellers W (2008) Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 27:5511–5526
Gu XB, Yang XJ, Hua Z, Lu ZH, Zhang B, Zhu YF, Wu HY, Jiang YM, Chen HK, Pei H (2012) Effect of oxymatrine on specific cytotoxic T lymphocyte surface programmed death receptor-1 expression in patients with chronic hepatitis B. Chin Med J 125:1434–1438
Guo B, Zhang T, Su J, Wang K, Lin X (2015) Oxymatrine targets EGFR p-Tyr845, and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells. Cancer Chemother Pharmacol 75:353–363
Hale AJ, Smith CA, Sutherland LC (1996) Apoptosis: molecular regulation of cell death. Eur J Biochem 236:1–26
Ho JW, Hon PN, Chim WO (2009) Effects of oxymatrine from Ku Shen on cancer cells. Anticancer Agents Med Chem 9:823–826
Jia J, Li S, Gong W, Ding J, Fang C, Quan Z (2011) Mda-7/IL-24 induces apoptosis in human GBC–SD gallbladder carcinoma cells via mitochondrial apoptotic pathway. Oncol Rep 25:195–201
Jin UH, Suh SJ, Chang HW, Son JK, Lee SH, Son KH, Chang YC, Kim CH (2008) Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signaling pathway. J Cell Biochem 104:15–26
Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB 10:77–82
Lao Y (2005) Clinical study on effect of matrine injection to protect the liver function for patients with primary hepatic carcinoma after trans-artery chemo-embolization (TAE). Zhong Yao Cai 28:637–638
Li M, Shen J, Wu X, Zhang B, Zhang R, Weng H, Ding Q, Tan Z, Gao G, Mu J, Yang J, Shu Y, Bao R, Ding Q, Wu W, Cao Y, Liu Y (2013) Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion. Med Oncol 30:1–8
Li J, Jiang K, Zhao F (2015) Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA-29b and downregulating matrix metalloproteinase-2 expression. Mol Med Rep 12:145–151
Liu F, He Y, Liang Y, Wen L, Zhu Y, Wu Y, Zhao LX, Li YS, Mao XL, Liu HY (2013a) PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinoma. Cancer Cell Int 13:1223–1227
Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, Cao Y, Li ML, Wu KJ, Liu YB (2013b) Curcumin induces apoptosis in gallbladder carcinoma cell line GBC–SD cells. Cancer Cell Int 13:1–9
Liu Y, Xu Y, Ji WD (2014) Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol 3:5111–5119
Miller G, Jarnagin WR (2008) Gallbladder carcinoma. Eur J Surg Oncol 34:306–312
Orrenius S (2006) Mitochondrial regulation of apoptotic cell death. Toxicol Lett 149:19–23
Pan L, Chai H, Kinghorn AD (2010) The continuing search for antitumor agents from higher plants. Phytochem Lett 3:1–8
Plati J, Bucur O, Khosravi-Far R (2011) Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) 3:279–296
Qin X, Yin J, Zhang H (2009) Effects of oxymatrine on proliferation of HepG2 cells. China J Chin Mater Med 34:1426–1429
Shao Q (2011) The recent effect of radiotherapy combined with compound kushen injection for esophageal cancer. Radiother Oncol 99:S372–S373
Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, Raina V, Shukla NK, Thulkar S, Garg P, Chaudhary SP (2010) Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol 28:4581–4586
Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M (1992) Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A Clinicopathologic study. Cancer 70:2747–2753
Song MQ, Zhu JS, Chen JL, Wang L, Da W, Li Zhu, Zhang WP (2007) Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells. World J Gastroenterol 13:1788–1793
Sun M, Cao H, Sun L, Dong S, Bian Y, Han J, Zhang L, Ren S, Hu Y, Liu C, Xu L, Liu P (2012a) Antitumor activities of kushen: literature review. Evid Based Complement Alternat Med 2012:373219
Sun Q, Ma W, Gao Y, Zheng W, Zhang B, Peng Y (2012b) Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma. Afr J Tradit Complement Altern Med 9:178–188
Tan Z, Zhang S, Li M, Wu X, Weng H, Ding Q, Cao Y, Bao R, Shu Y, Mu J, Ding Q, Wu W, Yang J, Zhang L, Liu Y (2013) Regulation of cell proliferation and migration in gallbladder cancer by zinc finger X-chromosomal protein. Gene 528:261–266
Tanioka Y, Yoshida T, Yagawa T, Saiki Y, Takeo S, Harada T, Okazawa T, Yanai H, Okita K (2004) Matrix metalloproteinase-7 and Matrix metalloproteinase-9 are associated with unfavourable prognosis in superfical oesophageal cancer. Br J Cancer 89:2116–2121
Valeriote F, Corbett T, Lorusso P, Moore RE, Scheuer P, Patterson G (2015) Anticancer agents from natural products. Pharm Biol 33:59–66
Wang YP, Zhao W, Xue R, Zhou ZX, Liu F, Han YX, Ren G, Peng ZG, Cen S, Chen HS, Li YH, Jiang JD (2011a) Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance. Antivir Res 89:227–231
Wang S, Yu S, Shi W, Ge L, Yu X, Fan J, Zhang J (2011b) Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life 63:775–782
Xie M, Yi X, Wang RJ, Zhu M, Qi C, Liu Y, Ye Y, Tan S, Tang A (2014) 14-thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro. Cell Physiol Biochem 33:1475–1483
Yang L, Yang L, Tian WC, Li J, Liu J, Zhu M, Zhang Y, Yang Y, Liu F, Zhang Q, Liu Q, Shen Y, Qi Z (2014) Resveratrol plays dual roles in pancreatic cancer cells. J Cancer Res Clin Oncol 140:749–755
Yun SJ, Kim WJ (2013) Role of the epithelial–mesenchymal transition in bladder cancer: from prognosis to therapeutic target. Korean J Urol 54:645–650
Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan HY, Luan GL, Yagasaki K, Zhang GY (2009) Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 59:191–200
Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S, Wu JB, Yu K, Han YX (2012) Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS ONE 7:e46853
Acknowledgements
This study was supported by the Program for integrative medicine of Suzhou City (No. SYSD2015163).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Liqiang Qian and Xiaqin Li contributed equally to this work.
Rights and permissions
About this article
Cite this article
Qian, L., Li, X., Ye, P. et al. Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway. Cytotechnology 70, 83–94 (2018). https://doi.org/10.1007/s10616-017-0153-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-017-0153-9